Skip to Main Content

Paper Details

Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.
Cancer Discov
97
2017
Author NameAffiliation
M Ryan CorcesCancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and Ludwig Center Stanford University School of Medicine
Ravindra MajetiStanford University School of Medicine
Ravindra MajetiCancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and Ludwig Center Stanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2